Alectinib for adjuvant treatment of ALK-positive non-small-cell lung cancer

Final draft guidance

Equality and health inequalities assessment (downloadable version) (PDF 123 KB)

Committee papers (PDF 4.88 MB)

Final draft guidance (PDF 118 KB)

Final scope (PDF 182 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 307 KB)

Equality impact assessment (Scoping) (PDF 127 KB)

Final stakeholder list (PDF 180 KB)

Draft scope post referral (PDF 202 KB)

Draft matrix post referral (PDF 181 KB)